Digital health, including telemedicine and wearables, will rely on trust, data safety and inclusive design to improve care.

A new drug, FLAV-27, targets epigenetic changes in Alzheimer’s. In preclinical studies, the drug reduced levels of ...

New Delhi [India], March 20: "Faces of Change" is a special feature dedicated to celebrating inspiring individuals who are driving meaningful transformation across industries. This initiative invites ...

But at least part of the credit for the stability I currently enjoy goes to an unlikely tool: the fitness tracking devices ...

AI Impact examines the race to deploy AI before governance can catch up, plus clinical use cases, risks and leadership moves.

Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...

As enterprises increasingly adopt autonomous systems and smart automation technologies, robotics is moving beyond traditional manufacturing to power logistics, healthcare, smart cities and advanced ...

But as these products proliferate, manufacturers face a new set of questions. How do expectations around comfort, usability, ...

AbbVie (ABBV) dropped 4.69% after FDA approved J&J's Icotyde psoriasis pill, creating fresh competition for blockbuster drug ...

There are several ways to sell skins in the Counter-Strike ecosystem. The most widely used option is the official Steam ...

Researchers developed FLAV-27, an epigenetic drug that inhibits G9a to restore gene expression in Alzheimer’s models. The treatment reduced amyloid and tau, improved cognition and synaptic function, ...

What should patients do before scheduling their first hearing test? According to a HelloNation article, Dr. Nicole Anzalone of Syracuse Hearing Solutions emphasizes that preparation improves accuracy ...